• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定糖尿病视网膜病变基于风险的筛查间隔:一项回顾性队列研究中风险算法的开发与验证

To Determine the Risk-Based Screening Interval for Diabetic Retinopathy: Development and Validation of Risk Algorithm from a Retrospective Cohort Study.

作者信息

Lian Jinxiao, So Ching, McGhee Sarah Morag, Thach Thuan-Quoc, Lam Cindy Lo Kuen, Fung Colman Siu Cheung, Kwong Alfred Siu Kei, Chan Jonathan Cheuk Hung

机构信息

School of Optometry, The Hong Kong Polytechnic University, Hong Kong.

School of Public Health, The University of Hong Kong, Hong Kong.

出版信息

Diabetes Metab J. 2025 Mar;49(2):286-297. doi: 10.4093/dmj.2024.0142. Epub 2024 Oct 31.

DOI:10.4093/dmj.2024.0142
PMID:39478439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11960201/
Abstract

BACKGRUOUND

The optimal screening interval for diabetic retinopathy (DR) remains controversial. This study aimed to develop a risk algorithm to predict the individual risk of referable sight-threatening diabetic retinopathy (STDR) in a mainly Chinese population and to provide evidence for risk-based screening intervals.

METHODS

The retrospective cohort data from 117,418 subjects who received systematic DR screening in Hong Kong between 2010 and 2016 were included to develop and validate the risk algorithm using a parametric survival model. The risk algorithm can be used to predict the individual risk of STDR within a specific time interval, or the time to reach a specific risk margin and thus to allocate a screening interval. The calibration performance was assessed by comparing the cumulative STDR events versus predicted risk over 2 years, and discrimination by using receiver operative characteristics (ROC) curve.

RESULTS

Duration of diabetes, glycosylated hemoglobin, systolic blood pressure, presence of chronic kidney disease, diabetes medication, and age were included in the risk algorithm. The validation of prediction performance showed that there was no significant difference between predicted and observed STDR risks in males (5.6% vs. 5.1%, P=0.724) or females (4.8% vs. 4.6%, P=0.099). The area under the receiver operating characteristic curve was 0.80 (95% confidence interval [CI], 0.78 to 0.81) for males and 0.81 (95% CI, 0.79 to 0.83) for females.

CONCLUSION

The risk algorithm has good prediction performance for referable STDR. Using a risk-based screening interval allows us to allocate screening visits disproportionally more to those at higher risk, while reducing the frequency of screening of lower risk people.

摘要

背景

糖尿病视网膜病变(DR)的最佳筛查间隔仍存在争议。本研究旨在开发一种风险算法,以预测主要为中国人群中可转诊的威胁视力的糖尿病视网膜病变(STDR)的个体风险,并为基于风险的筛查间隔提供证据。

方法

纳入2010年至2016年在香港接受系统性DR筛查的117418名受试者的回顾性队列数据,使用参数生存模型开发并验证风险算法。该风险算法可用于预测特定时间间隔内STDR的个体风险,或达到特定风险阈值的时间,从而分配筛查间隔。通过比较2年内累积的STDR事件与预测风险来评估校准性能,并使用受试者操作特征(ROC)曲线进行鉴别。

结果

风险算法纳入了糖尿病病程、糖化血红蛋白、收缩压、慢性肾病的存在、糖尿病用药情况和年龄。预测性能验证显示,男性预测的和观察到的STDR风险之间无显著差异(5.6%对5.1%,P = 0.724),女性也无显著差异(4.8%对4.6%,P = 0.099)。男性受试者操作特征曲线下面积为0.80(95%置信区间[CI],0.78至0.81),女性为0.81(95%CI,0.79至0.83)。

结论

该风险算法对可转诊的STDR具有良好的预测性能。使用基于风险的筛查间隔使我们能够将筛查就诊不成比例地更多分配给高风险人群,同时减少低风险人群的筛查频率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea2/11960201/780c27236a0b/dmj-2024-0142f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea2/11960201/1898620b8338/dmj-2024-0142f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea2/11960201/18bb299c2270/dmj-2024-0142f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea2/11960201/780c27236a0b/dmj-2024-0142f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea2/11960201/1898620b8338/dmj-2024-0142f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea2/11960201/18bb299c2270/dmj-2024-0142f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea2/11960201/780c27236a0b/dmj-2024-0142f3.jpg

相似文献

1
To Determine the Risk-Based Screening Interval for Diabetic Retinopathy: Development and Validation of Risk Algorithm from a Retrospective Cohort Study.确定糖尿病视网膜病变基于风险的筛查间隔:一项回顾性队列研究中风险算法的开发与验证
Diabetes Metab J. 2025 Mar;49(2):286-297. doi: 10.4093/dmj.2024.0142. Epub 2024 Oct 31.
2
Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study.中国糖尿病视网膜病变的患病率及危险因素:一项基于多医院的横断面研究。
Br J Ophthalmol. 2017 Dec;101(12):1591-1595. doi: 10.1136/bjophthalmol-2017-310316. Epub 2017 Aug 30.
3
External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus.一种用于调整糖尿病患者眼部筛查就诊频率的风险评估模型的外部验证
J Diabetes Complications. 2015 May-Jun;29(4):508-11. doi: 10.1016/j.jdiacomp.2014.12.020. Epub 2015 Jan 8.
4
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.意大利东北部长达十年的糖尿病视网膜病变远程医疗筛查项目。
J Diabetes Complications. 2017 Aug;31(8):1348-1353. doi: 10.1016/j.jdiacomp.2017.04.010. Epub 2017 Apr 13.
5
Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.在既定的城市筛查计划中,威胁视力的糖尿病视网膜病变的发病率:一项为期 11 年的队列研究。
Diabet Med. 2021 Sep;38(9):e14583. doi: 10.1111/dme.14583. Epub 2021 Jun 9.
6
Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy.2 型糖尿病患者视力威胁性糖尿病视网膜病变预测的视网膜病变风险计算器:FIELD 子研究。
Diabetes Res Clin Pract. 2022 Apr;186:109835. doi: 10.1016/j.diabres.2022.109835. Epub 2022 Mar 18.
7
Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme.17 年大型英国社区为基础的糖尿病视网膜病变筛查项目中产量趋势和筛查间隔的效果。
Diabet Med. 2009 Oct;26(10):1040-7. doi: 10.1111/j.1464-5491.2009.02820.x.
8
Validation of Deep Convolutional Neural Network-based algorithm for detection of diabetic retinopathy - Artificial intelligence versus clinician for screening.基于深度卷积神经网络的糖尿病视网膜病变检测算法的验证 - 人工智能与临床医生用于筛查的比较。
Indian J Ophthalmol. 2020 Feb;68(2):398-405. doi: 10.4103/ijo.IJO_966_19.
9
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort study.在糖尿病眼病筛查中,威胁视力的糖尿病视网膜病变进展率的种族差异:一项基于人群的回顾性队列研究。
BMJ Open Diabetes Res Care. 2023 Nov;11(6). doi: 10.1136/bmjdrc-2023-003683.
10
Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.基于个体风险的糖尿病视网膜病变筛查:多变量方法与分层规则的应用比较。
Diabetes Obes Metab. 2019 Mar;21(3):560-568. doi: 10.1111/dom.13552. Epub 2018 Oct 30.

本文引用的文献

1
Patient referral flow between physician and ophthalmologist visits for diabetic retinopathy screening among Japanese patients with diabetes: A retrospective cross-sectional cohort study using the National Database.利用国家数据库对日本糖尿病患者的糖尿病视网膜病变筛查中,医生和眼科医生就诊之间的患者转诊流程:一项回顾性横断面队列研究。
J Diabetes Investig. 2023 Jul;14(7):883-892. doi: 10.1111/jdi.14018. Epub 2023 May 2.
2
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.个体化糖尿病视网膜病变筛查的安全性和成本效益:ISDR 开放性标签、等效 RCT。
Diabetologia. 2021 Jan;64(1):56-69. doi: 10.1007/s00125-020-05313-2. Epub 2020 Nov 4.
3
Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis.
韩国糖尿病患者的糖尿病视网膜病变及相关临床实践:一项 10 年趋势分析。
Diabetes Metab J. 2020 Dec;44(6):928-932. doi: 10.4093/dmj.2020.0096. Epub 2020 Jul 10.
4
Diabetic Retinopathy Preferred Practice Pattern®.糖尿病视网膜病变首选诊疗模式®
Ophthalmology. 2020 Jan;127(1):P66-P145. doi: 10.1016/j.ophtha.2019.09.025. Epub 2019 Sep 25.
5
Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). . 2017;7:1-59.勘误:肾脏疾病:改善全球预后(KDIGO)慢性肾脏病-矿物质和骨异常(CKD-MBD)更新工作组。KDIGO 2017慢性肾脏病-矿物质和骨异常(CKD-MBD)诊断、评估、预防及治疗临床实践指南更新。. 2017;7:1-59。
Kidney Int Suppl (2011). 2017 Dec;7(3):e1. doi: 10.1016/j.kisu.2017.10.001. Epub 2017 Nov 17.
6
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine.基于个体变量间隔的糖尿病视网膜病变致盲风险筛查:利物浦风险计算引擎。
Diabetologia. 2017 Nov;60(11):2174-2182. doi: 10.1007/s00125-017-4386-0. Epub 2017 Aug 24.
7
A Clinical Practice Guideline to Guide a System Approach to Diabetes Care in Hong Kong.《香港糖尿病护理系统方法临床实践指南》
Diabetes Metab J. 2017 Apr;41(2):81-88. doi: 10.4093/dmj.2017.41.2.81.
8
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.1型糖尿病视网膜病变循证筛查的频率
N Engl J Med. 2017 Apr 20;376(16):1507-1516. doi: 10.1056/NEJMoa1612836.
9
Five-year cost-effectiveness of the Patient Empowerment Programme (PEP) for type 2 diabetes mellitus in primary care.患者赋权计划(PEP)在初级保健中治疗 2 型糖尿病的 5 年成本效益分析。
Diabetes Obes Metab. 2017 Sep;19(9):1312-1316. doi: 10.1111/dom.12919. Epub 2017 May 5.
10
Diabetic retinopathy screening: global and local perspective.糖尿病视网膜病变筛查:全球及本地视角
Hong Kong Med J. 2016 Oct;22(5):486-95. doi: 10.12809/hkmj164844. Epub 2016 Aug 26.